GOBBINI, ANDREA
GOBBINI, ANDREA
DIPARTIMENTO DI BIOTECNOLOGIE E BIOSCIENZE
Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients
2021 Notarbartolo, S; Ranzani, V; Bandera, A; Gruarin, P; Bevilacqua, V; Putignano, A; Gobbini, A; Galeota, E; Manara, C; Bombaci, M; Pesce, E; Zagato, E; Favalli, A; Sarnicola, M; Curti, S; Crosti, M; Martinovic, M; Fabbris, T; Marini, F; Donnici, L; Lorenzo, M; Mancino, M; Ungaro, R; Lombardi, A; Mangioni, D; Muscatello, A; Aliberti, S; Blasi, F; De Feo, T; Prati, D; Manganaro, L; Granucci, F; Lanzavecchia, A; De Francesco, R; Gori, A; Grifantini, R; Abrignani, S
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations
2022 Favalli, A; Favalli, E; Gobbini, A; Zagato, E; Bombaci, M; Maioli, G; Pesce, E; Donnici, L; Gruarin, P; Biggioggero, M; Curti, S; Manganaro, L; Marchisio, E; Bevilacqua, V; Martinovic, M; Fabbris, T; Sarnicola, M; Crosti, M; Marongiu, L; Granucci, F; Notarbartolo, S; Bandera, A; Gori, A; De Francesco, R; Abrignani, S; Caporali, R; Grifantini, R
Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study(Front. Med., (2022), 9, (850858), 10.3389/fmed.2022.850858)
2022 Favalli, E; Gobbini, A; Bombaci, M; Maioli, G; Biggioggero, M; Pesce, E; Favalli, A; Martinovic, M; Fabbris, T; Marchisio, E; Bandera, A; Gori, A; Abrignani, S; Grifantini, R; Caporali, R